| Title | Authors / Editors | Date |
unige:104794 |
Risk of recurrent venous thromboembolism according to baseline risk factor profiles |
Prins, Martin H; Lensing, Anthonie W A; Prandoni, Paolo; Wells, Philip S; ... Weitz, Jeffrey I |
2018 |
unige:101397 |
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism |
Weitz, Jeffrey I; Lensing, Anthonie W A; Prins, Martin H; Bauersachs, Rupert; ... Prandoni, Paolo |
2017 |
unige:101427 |
Choosing wisely: The impact of patient selection on efficacy and safety outcomes in the EINSTEIN-DVT/PE and AMPLIFY trials |
Beyer-Westendorf, Jan; Lensing, Anthonie W A; Arya, Roopen; Bounameaux, Henri; ... Weitz, Jeffrey I |
2017 |
unige:86256 |
Treatment of venous thromboembolism with rivaroxaban in relation to body weight. A sub-analysis of the EINSTEIN DVT/PE studies |
Di Nisio, Marcello; Vedovati, Maria C; Riera-Mestre, Antoni; Prins, Martin H; ... Lensing, Anthonie W A |
2016 |
unige:91080 |
Long-term Anticoagulation With Rivaroxaban for Preventing Recurrent VTE: A Benefit-Risk Analysis of EINSTEIN-Extension |
Wells, Philip S; Prins, Martin H; Levitan, Bennett; Beyer-Westendorf, Jan; ... Lensing, Anthonie W A |
2016 |
unige:78950 |
Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use |
Martinelli, Ida; Lensing, Anthonie W A; Middeldorp, Saskia; Levi, Marcel; ... Prins, Martin H |
2016 |
unige:29957 |
Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies |
Prins, Martin H; Lensing, Anthonie Wa; Bauersachs, Rupert; van Bellen, Bonno; ... Wells, Philip S |
2013 |